Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

HIV Health and Treatment Issues >> Treatment & Side Effects

Subject Poster Views Replies Posted on
. . Hair loss and skin rash on stribild.....? Dadof4 7371 6    01/11/14 09:41 PM
. . Cost of Combivir (Duovir) and Cost of efavirenz(Sustiva) in Canada raj1984 1536 0    09/12/13 02:38 PM
. . viral load still did not suppress usign38 3224 8    07/30/14 03:14 AM
. . ARV combination mark4586lopez 1797 3    07/30/14 12:13 AM
. . Here we go again.. New regimen... bscottmatt 3778 6    07/30/14 12:22 AM
. . (1 year update) Atripla side effects (what not someone else with Atripla Drama) Kenn 5608 5    08/27/13 11:52 PM
. . Dramamine and HIV Meds? Ninjawife 2627 3    08/15/13 11:54 PM
. . Reyetaz, Norvir and Truvada bscottmatt 4563 9    08/31/13 09:01 PM
. . Interferon Roferon Peginterfeon Side Effects Claude 2966 2    02/19/14 12:18 PM
. . Question about Atripla side effects. Rochambeau 4045 5    07/20/13 01:40 AM
. . Eviplera and Maraviroc Side Effects philfromoz 2274 2    07/02/13 11:44 AM
. . are you having any sideaffects on stribild SOUTHERN36078 1585 3    08/28/13 05:12 PM
. . HIV medication and antihistamines Mark100 5416 3    05/10/13 09:49 PM
. . mthod may aid hiv patients raymond 2101 3    05/08/13 12:38 AM
. . Treatment for international students in usa hivstudent 1743 1    05/23/13 12:42 AM
. . Prezsista, Norvir and Truvada tcocoa 2726 2    04/22/13 11:49 AM
. . Isentress,reyataz, selzentry ,horrible bladder/ colon/ joint pains Ginger35 2349 1    09/27/13 12:27 PM
. . Just a question about my medication pozmedic 2768 5    08/23/13 10:40 PM
. . Starting Complera Gizmo 2575 3    05/21/13 12:38 AM
. . Doctor bad experience JohnMarson90 5490 7    04/20/13 11:04 PM
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 >>

Show
Jump to
Search forum

What's New at TheBody.com

Contact Us | Privacy Statement The Body

*
UBB.threads™ 6.2.3